Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard Romero
Richard Romero
Oregon Health & Science University
Nilotinib
ABL
Imatinib
Dasatinib
Biology
5
Papers
89
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Mass spectrometry guided in situ proteolysis to obtain crystals for X-ray structure determination.
2010
Journal of the American Society for Mass Spectrometry
T. Gheyi
L. Rodgers
Richard Romero
J. Michael Sauder
S.K. Burley
Show All
Source
Cite
Save
Citations (12)
SGX70393 inhibits the T315I mutant of Bcr-Abl kinase and pre-empts drug resistance when combined with nilotinib or dasatinib
2007
Molecular Cancer Therapeutics
Thomas OHare
Christopher A. Eide
Jeffrey W. Tyner
Amie S. Corbin
Matthew J. Wong
Sean Buchanan
Kevin Holme
Katayoun Jessen
Crystal Tang
Hal A. Lewis
Richard Romero
Stephen K. Burley
Michael W. Deininger
Show All
Source
Cite
Save
Citations (0)
SGX70393 Inhibits Bcr-AblT315I In Vitro and In Vivo and Completely Suppresses Resistance When Combined with Nilotinib or Dasatinib.
2007
Blood
Thomas O’Hare
Christopher A. Eide
Jeffrey W. Tyner
Amie S. Corbin
Matthew J. Wong
Sean Buchanan
Kevin Holme
Katayoun Jessen
Crystal Tang
Hal A. Lewis
Richard Romero
Stephen K. Burley
Michael W. Deininger
Show All
Source
Cite
Save
Citations (2)
1